Ravanat C, Gachet C, Herbert J M, Schuhler S, Guillemot J C, Uzabiaga F, Picard C, Ferrara P, Freund M, Cazenave J P
INSERM U311, Centre Régional de Transfusion Sanguine, Strasbourg, France.
Eur J Biochem. 1994 Jul 1;223(1):203-10. doi: 10.1111/j.1432-1033.1994.tb18984.x.
Platelet factor 4 is a heparin-binding protein released from the alpha granules of activated platelets. This study describes the purification and identification of two forms of rat platelet factor 4, the previously characterized non-glycosylated form of 7 kDa and an additional glycosylated form of molecular mass 9 kDa. The two proteins both neutralized the antithrombin-III-dependent inhibitory activity of heparin. Although their amino acid composition was found to be the same, in the N-terminal sequence of the 9-kDa protein, the second threonine residue could not be detected and a difference of 976Da was determined by mass spectrometry. After digestion with O-glycanase and sialidase, the two proteins showed the same molecular mass. Overall consideration of these data led to identification of the higher-molecular-mass protein as a glycosylated form of rat platelet factor 4 with O-glycosylation at the second N-terminal amino acid, while the structure of the oligosaccharide core was established by mass spectrometry and sugar differentiation with lectins. The two forms of platelet factor 4 are both present in platelets and secreted after platelet activation.
血小板因子4是一种从活化血小板的α颗粒中释放的肝素结合蛋白。本研究描述了两种形式的大鼠血小板因子4的纯化和鉴定,一种是先前已鉴定的7 kDa非糖基化形式,另一种是分子量为9 kDa的糖基化形式。这两种蛋白质均能中和肝素的抗凝血酶III依赖性抑制活性。尽管发现它们的氨基酸组成相同,但在9 kDa蛋白质的N端序列中,第二个苏氨酸残基无法检测到,质谱分析确定其分子量相差976Da。用O-糖苷酶和唾液酸酶消化后,这两种蛋白质显示出相同的分子量。综合考虑这些数据,确定分子量较高的蛋白质为大鼠血小板因子4的糖基化形式,其N端第二个氨基酸发生了O-糖基化,而寡糖核心的结构通过质谱分析和凝集素糖分化得以确定。两种形式的血小板因子4均存在于血小板中,并在血小板活化后分泌。